city New Delhi India hospital covid-19 patient city New Delhi India

Monoclonal antibody treatment combo effective against mild-moderate covid: Study

Reading now: 548
www.livemint.com

NEW DELHI : Combination of casirivimab and imdevimab―two monoclonal antibody treatments—keep high-risk patients out of the hospital when infected with mild to moderate covid-19, a study published in The Lancet's EClinicalMedicine has showed.

The observational study was done by researchers of Mayo Clinic, a non-profit organization working on innovation in clinical practice, education and research.

Monoclonal antibodies are also prescribed in India. Nearly 1,400 Mayo Clinic patients were enrolled in the study; 696 of them received the drug combo between December 2020 and early April, while an equal matched cohort did not receive it.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA